Treatment of Refractory Status Epilepticus with Pentobarbital, Propofol, or Midazolam: A Systematic Review

Summary:  Background: New continuous infusion antiepileptic drugs (cIV‐AEDs) offer alternatives to pentobarbital for the treatment of refractory status epilepticus (RSE). However, no prospective randomized studies have evaluated the treatment of RSE. This systematic review compares the efficacy of midazolam (MDL), propofol (PRO), and pentobarbital (PTB) for terminating seizures and improving outcome in RSE patients.

[1]  M. Aminoff,et al.  Barbiturate anesthesia in the treatment of status epilepticus , 1988, Neurology.

[2]  F. Drislane,et al.  Depth of EEG Suppression and Outcome in Barbiturate Anesthetic Treatment for Refractory Status Epilepticus , 1999, Epilepsia.

[3]  M. C. McBride,et al.  Status epilepticus. , 2016, Pediatrics in review.

[4]  M. Aminoff,et al.  Status epilepticus: Causes, clinical features and consequences in 98 patients , 1980 .

[5]  P. Ness Pentobarbital and EEG Burst Suppression in Treatment of Status Epilepticus Refractory to Benzodiazepines and Phenytoin , 1990 .

[6]  S. Pugh,et al.  PROPOFOL INFUSION FOR THE TREATMENT OF STATUS EPILEPTICUS , 1988, The Lancet.

[7]  S. Tuhrim,et al.  Treatment of Refractory Complex‐Partial Status Epilepticus with Propofol: Case Report , 2000, Epilepsia.

[8]  B. Psaty,et al.  When you look for evidence and find too much , 1998, Neurology.

[9]  P. Teiken,et al.  Propofol for treating status epilepticus , 1994 .

[10]  D. Naritoku,et al.  Prolongation of midazolam half-life after sustained infusion for status epilepticus , 2000, Neurology.

[11]  M. Stecker,et al.  Treatment of Refractory Status Epilepticus with Propofol: Clinical and Pharmacokinetic Findings , 1998, Epilepsia.

[12]  M. Walker,et al.  The intensive care treatment of convulsive status epilepticus in the UK , 1995, Anaesthesia.

[13]  E. Bertram,et al.  Propofol and Midazolam in the Treatment of Refractory Status Epilepticus , 2001, Epilepsia.

[14]  A. Burstein,et al.  Midazolam in Refractory Status Epilepticus , 1996, The Annals of pharmacotherapy.

[15]  T. Bleck Advances in the management of refractory status epilepticus. , 1993, Critical care medicine.

[16]  R. Hill,et al.  Potentiation of GABA by Midazolam and Its Therapeutic Effect against Status Epilepticus , 1983, Folia psychiatrica et neurologica japonica.

[17]  R. Ramsay,et al.  Double-blind study of lorazepam and diazepam in status epilepticus. , 1983, JAMA.

[18]  W. Hauser,et al.  Short‐Term Mortality After a First Episode of Status Epilepticus , 1997, Epilepsia.

[19]  S. Mayer,et al.  Continuous EEG monitoring and midazolam infusion for refractory nonconvulsive status epilepticus , 2001, Neurology.

[20]  E. Draper,et al.  APACHE II: A severity of disease classification system , 1985, Critical care medicine.

[21]  H. Yanny,et al.  Propofol infusions for status epilepticus , 1988, Anaesthesia.

[22]  R. Delorenzo,et al.  Treatment of convulsive status epilepticus. Recommendations of the Epilepsy Foundation of America's Working Group on Status Epilepticus. , 1993, JAMA.

[23]  E. Gepts,et al.  Pharmacokinetic Implications for the Clinical Use of Propofol , 1989, Clinical pharmacokinetics.

[24]  E. Waterhouse,et al.  Prospective Population‐Based Study of Intermittent and Continuous Convulsive Status Epilepticus in Richmond, Virginia , 1999, Epilepsia.

[25]  T. Bleck,et al.  New anticonvulsant drugs. Focus on flunarizine, fosphenytoin, midazolam and stiripentol. , 1994, Drugs.

[26]  C H Schmid,et al.  Large trials vs meta-analysis of smaller trials : How do their results compare ? , 1996 .

[27]  D. Lowenstein,et al.  Treatment of refractory generalized status epilepticus with continuous infusion of midazolam , 1994, Neurology.

[28]  B. Orser,et al.  Propofol modulates activation and desensitization of GABAA receptors in cultured murine hippocampal neurons , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[29]  T. Bleck,et al.  Intravenous midazolam for the treatment of refractory status epilepticus , 1992, Critical care medicine.

[30]  Foss Mv MANAGEMENT OF VIRUS HEPATITIS. , 1964 .

[31]  P. V. Van Ness Pentobarbital and EEG burst suppression in treatment of status epilepticus refractory to benzodiazepines and phenytoin. , 1990, Epilepsia.

[32]  K. Yaffe,et al.  Prognostic factors of pentobarbital therapy for refractory generalized status epilepticus , 1993, Neurology.

[33]  M. Krom,et al.  Status epilepticus during vigabatrin treatment: A report of three cases , 1995, Seizure.

[34]  F. Kapadia,et al.  Propofol infusion for control of status epilepticus , 1990, Anaesthesia.

[35]  D. Hanley,et al.  Prolonged pentobarbital and phenobarbital coma for refractory generalized status epilepticus. , 1995, Critical care medicine.

[36]  K. Merigian,et al.  Successful treatment of amoxapine-induced refractory status epilepticus with propofol (diprivan) , 1995, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[37]  S. Shorvon Status Epilepticus: Its Clinical Features and Treatment in Children and Adults , 1994 .

[38]  R. Gannon,et al.  Continuous infusion of midazolam hydrochloride to control status epilepticus. , 1988, Clinical pharmacy.

[39]  D. Hanley,et al.  Use of midazolam in the treatment of refractory status epilepticus. , 1998, Clinical therapeutics.

[40]  F Davidoff,et al.  Systematic Reviews: Critical Links in the Great Chain of Evidence , 1997, Annals of Internal Medicine.

[41]  J. Pellock,et al.  Determinants of Mortality in Status Epilepticus , 1994, Epilepsia.

[42]  C. Chilvers,et al.  Successful use of propofol in status epilepticus , 1990, Anaesthesia.

[43]  W. Blume,et al.  Anesthetic Barbiturates in Refractory Status Epilepticus , 1980, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[44]  I. Osorio,et al.  Treatment of Refractory Generalized Tonic‐Clonic Status Epilepticus with Pentobarbital Anesthesia After High‐Dose Phenytoin , 1989, Epilepsia.

[45]  B. Uthman,et al.  A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. , 1998, The New England journal of medicine.

[46]  Jan Claassen,et al.  Refractory status epilepticus: frequency, risk factors, and impact on outcome. , 2002, Archives of neurology.

[47]  G. Grégoire,et al.  Discrepancies between meta-analyses and subsequent large randomized, controlled trials. , 1997, The New England journal of medicine.

[48]  J. Steinbach,et al.  Structural domains of the human GABAA receptor β3 subunit involved in the actions of pentobarbital , 2000, The Journal of physiology.

[49]  J. Villar,et al.  Predictive ability of meta-analyses of randomised controlled trials , 1995, The Lancet.

[50]  R. E. Adams,et al.  Midazolam treatment of acute and refractory status epilepticus. , 1999, Clinical neuropharmacology.

[51]  P. Penovich,et al.  Pentobarbital treatment of refractory status epilepticus , 1987, Neurology.

[52]  A. Vinattieri,et al.  Propofol in the treatment of convulsive status epilepticus: a report of four cases. , 1991, Rivista di neurologia.

[53]  Fountain Nb,et al.  Midazolam treatment of acute and refractory status epilepticus. , 1999 .

[54]  G. Levin,et al.  Role of Propofol in Refractory Status Epilepticus , 1998, The Annals of pharmacotherapy.

[55]  P. Suter,et al.  The Nonhypnotic Therapeutic Applications of Propofol , 1994, Anesthesiology.

[56]  E. Waterhouse,et al.  Persistent Nonconvulsive Status Epilepticus After the Control of Convulsive Status Epilepticus , 1998, Epilepsia.

[57]  F. Drislane,et al.  Relapse and Survival After Barbiturate Anesthetic Treatment of Refractory Status Epilepticus , 1996, Epilepsia.

[58]  D. Lowenstein,et al.  Status epilepticus at an urban public hospital in the 1980s , 1993, Neurology.

[59]  D. Faulds,et al.  Propofol. An update of its use in anaesthesia and conscious sedation. , 1995, Drugs.

[60]  R. Ramsay Treatment of Status Epilepticus , 1993, Epilepsia.